AptarGroup (NYSE:ATR – Get Free Report) is expected to be releasing its Q3 2026 results after the market closes on Thursday, October 29th. Analysts expect AptarGroup to post earnings of $1.47 per share and revenue of $980.76 million for the quarter. AptarGroup has set its Q3 2026 guidance at 1.450-1.530 EPS. Parties can find conference call details on the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Friday, October 30, 2026 at 9:00 AM ET.
AptarGroup (NYSE:ATR – Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The industrial products company reported $1.42 EPS for the quarter, topping analysts’ consensus estimates of $1.35 by $0.07. The business had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.01 billion. AptarGroup had a return on equity of 13.31% and a net margin of 9.22%. AptarGroup’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period last year, the company posted $1.66 earnings per share. On average, analysts expect AptarGroup to post $5.47 EPS for the current fiscal year and $6.14 EPS for the next fiscal year.
AptarGroup Stock Up 0.5%
Shares of NYSE:ATR opened at $127.21 on Tuesday. The company has a market capitalization of $8.09 billion, a PE ratio of 23.00, a price-to-earnings-growth ratio of 3.92 and a beta of 0.34. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.61 and a quick ratio of 1.10. The business has a fifty day moving average price of $126.13 and a two-hundred day moving average price of $126.83. AptarGroup has a 1 year low of $103.23 and a 1 year high of $146.91.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft started coverage on AptarGroup in a research note on Wednesday, October 7th. They set a “buy” rating and a $150.00 target price on the stock. Wells Fargo & Company raised their price objective on shares of AptarGroup from $145.00 to $155.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. UBS Group initiated coverage on shares of AptarGroup in a report on Friday, October 9th. They set a “neutral” rating and a $135.00 price objective for the company. Bank of America raised shares of AptarGroup from a “neutral” rating to a “buy” rating and set a $173.00 price objective on the stock in a research report on Tuesday, July 14th. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $160.00 target price on shares of AptarGroup in a research note on Wednesday, July 15th. Six research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $164.14.
Read Our Latest Analysis on AptarGroup
Insider Transactions at AptarGroup
In other AptarGroup news, CEO Gael Touya sold 3,740 shares of the business’s stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $133.76, for a total value of $500,262.40. Following the sale, the chief executive officer directly owned 29,102 shares in the company, valued at $3,892,683.52. The trade was a 11.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Stephan Tanda sold 9,838 shares of AptarGroup stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $136.16, for a total value of $1,339,542.08. Following the completion of the sale, the chief executive officer directly owned 238,729 shares of the company’s stock, valued at approximately $32,505,340.64. This trade represents a 3.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 23,197 shares of company stock valued at $3,134,828. Corporate insiders own 0.73% of the company’s stock.
About AptarGroup
AptarGroup, Inc (NYSE: ATR) develops and manufactures dispensing, sealing and delivery systems for the pharmaceutical, beauty, personal care, food and beverage markets. Its products are designed to control, protect and dispense a wide range of liquids, creams, lotions, fragrances and other formulations.
The company’s offerings include pumps, valves, closures, aerosol systems and other dispensing components, as well as drug-delivery technologies. Through its pharmaceutical business, Aptar supports nasal, pulmonary, ophthalmic, dermal and injectable applications, serving pharmaceutical and biotechnology companies with components and systems used in prescription, over-the-counter and consumer health products.
Aptar serves customers internationally through manufacturing, research and development and commercial operations across North America, Europe, Asia and other global markets.
Further Reading
- Five stocks we like better than AptarGroup
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.
